Mouse Monoclonal to ABRA1
ABRA1-01 (IgG)
Technical Information Request
Inquiry for Bulk Prices
|
Product No. |
Form |
Quantity |
Stock |
Price |
Datasheet |
Shop |
| |
11-619-C025 |
purified |
0.025 mg |
 |
choose region |
  |
 |
| |
11-619-C100 |
purified |
0.1 mg |
 |
choose region |
  |
 |

- In stock! Ready for immediate despatch

- Manufacture on order
Background
ABRA1 (Abraxas), also known as CCDC98, is an adaptor protein that is essential for formation and function of BRCA1 A tumor suppressor complex. This complex plays critical roles in DNA repair, cell cycle checkpoint control, and maintenance of genomic stability. ABRA1 mediates interaction of ubiquitin-interacting motif-containing protein RAP80 and deubiquitination enzyme BRCC36 with BRCA1/BARD1. ABRA1 controls both DNA-damage-induced formation of BRCA1 foci and BRCA1-dependent G2/M checkpoint activation.
Specificity
The mouse monoclonal antibody ABRA1-01 recognizes N-terminal part of ABRA1 (Abraxas, CCDC98), an adaptor protein involved in DNA repair, which migrates as a 45 kDa band on PAAGE under reducing conditions.
Immunogen
Recombinant protein corresponding to amino acids 1-313 of ABRA1 with N-terminal His6 tag
Species Reactivity:
Negative Species:
|
Applications:
Usage note: Indicated dilutions are recommended starting points for use of this product. Working concentrations should be determined by the investigator.
|
General references
*Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ: Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science. 2007 May 25;316(5828):1194-8.
[Abstract]
*Liu Z, Wu J, Yu X: CCDC98 targets BRCA1 to DNA damage sites. Nat Struct Mol Biol. 2007 Aug;14(8):716-20.
[Abstract]
*Wang B, Elledge SJ: Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20759-63.
[Abstract] [Full Text]
*Nikkilä J, Coleman KA, Morrissey D, Pylkäs K, Erkko H, Messick TE, Karppinen SM, Amelina A, Winqvist R, Greenberg RA: Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. Oncogene. 2009 Apr 23;28(16):1843-52.
[Abstract] [Full Text]
|
For research use only. Not for drug, diagnostic or other use.
Example Data

Fig. 1.
Fig. 1. Detection of ABRA1-EGFP fusion protein in lysate of transfected HEK293 cells.
Lane A: Immunostaining with anti-ABRA1 (clone
ABRA1-01)
Lane B: Immunostaining with anti-EGFP (polyclonal)
Lane C: Immunostaining with anti-alpha tubulin (clone TU-01)